Latest News & Updates
Breaking News
10 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
OrganaBio Acquires Excellos Assets to Expand Cell Therapy CDMO Capacity in San Diego
OrganaBio acquires Excellos assets and launches Excellos Labs subsidiary to expand GMP cell therapy CDMO capacity in San Diego.
Pharma Now Editorial Team
SN Bioscience Achieves First Patient Dosing in Global Phase I SCLC Trial for SNB-101
SN Bioscience doses first patient in a global Phase I trial of SNB-101 for SCLC, backed by an 83.3% disease control rate in prior high-dose cohorts.
Pharma Now Editorial Team
Pfizer Appoints Ashish Doshi as Director at IITM Research Park Chennai Facility
Pfizer promotes Ashish Doshi to Director at IITM Research Park Chennai, reinforcing QA and regulatory leadership at a key India site.
Pharma Now Editorial Team
Bayer's NUBEQA Combination Achieves 71% Risk Reduction in Phase II Metastatic Prostate Cancer Trial
Bayer's NUBEQA combination cut progression or death risk by 71% in Phase II, but open-label design and lack of randomization limit regulatory weight.
Pharma Now Editorial Team
